AI-generated summary
The authors studied photobiomodulation therapy, a form of light therapy, on the gastrocnemius muscle of mdx mice, a model of Duchenne muscular dystrophy, at three stages of disease. They report that treatment was associated with reduced inflammation, macrophage infiltration and other tissue markers across all stages, and they describe the therapy as promising while calling for human research to verify efficacy.
- Who or what was studied
- X-linked muscular dystrophy (mdx) mice, a model of Duchenne muscular dystrophy
- Limits stated in the abstract
- The study was conducted in mice rather than humans, and the abstract states that further research in humans is needed to verify efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jmpt.kglmeridian.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 0.6 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.